- Home
- APH vs ABT Comparison
APH vs ABT Comparison
Compare APH & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APH | ABT |
|---|---|---|
| Founded | 1932 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.5B | 173.2B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | APH | ABT |
|---|---|---|
| Price | $86.17 | $102.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 28 |
| Target Price | $102.18 | ★ $120.72 |
| AVG Volume (30 Days) | ★ 10.4M | 5.4M |
| Earning Date | 10-28-2026 | 10-21-2026 |
| Dividend Yield | 0.57% | ★ 2.53% |
| EPS Growth | ★ 73.96 | N/A |
| EPS | ★ 2.10 | 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $54.19 | $13.25 |
| Revenue Next Year | $19.63 | $8.62 |
| P/E Ratio | ★ $41.43 | $163.21 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $77.00 | $81.97 |
| 52 Week High | $178.52 | $133.34 |
Technical Indicators
Market Signals| Indicator | APH | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 35.39 | 50.29 |
| Support Level | $77.00 | $100.60 |
| Resistance Level | $154.81 | $104.19 |
| Average True Range (ATR) | 2.11 | 2.05 |
| MACD | 3.00 | 0.29 |
| Stochastic Oscillator | 62.25 | 69.50 |
Price Performance
Historical ComparisonAbout APH Amphenol Corporation
Amphenol is a global supplier of connectors, sensors, and interconnect systems. It holds the second-largest connector market share globally and sells into the automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile networks end markets. Amphenol is diversified geographically, with operations in 40 countries.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.